George Yancopoulos - Feb 15, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**George D. Yancopoulos
Stock symbol
REGN
Transactions as of
Feb 15, 2024
Transactions value $
-$48,863,868
Form type
4
Date filed
2/20/2024, 04:03 PM
Previous filing
Jan 4, 2024
Next filing
May 1, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -173K -100% $0.00* 0 Feb 15, 2024 Common Stock 173K $399.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As investment trustee of trusts for the benefit of the reporting person's children.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.